Physical urticaria

Current Allergy and Asthma Reports

Volumn 12, Issue 4, 2012, Pages 281-287

  Abajian, Marina ^a   Młynek, Agnieszka ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Delayed pressure urticaria; Physical urticaria; Symptomatic dermographism; Urticaria factitia

Indexed keywords

AFAMELANOTIDE; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; DAPSONE; ETANERCEPT; IMMUNOGLOBULIN; OMALIZUMAB; RECOMBINANT ANTIBODY; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC URTICARIA; CLINICAL FEATURE; COLD URTICARIA; DELAYED PRESSURE URTICARIA; DERMOGRAPHISM; DISEASE DURATION; DRUG EFFICACY; HEAT CONTACT URTICARIA; HEAT URTICARIA; HUMAN; PHOTOTHERAPY; PHYSICAL URTICARIA; PROVOCATION TEST; SKIN TEST; SOLAR URTICARIA; THERAPY EFFECT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA;

EID: 84865596459     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0269-0     Document Type: Article

References (64)

1. Kontou-Fili K, Borici-Mazi R, Kapp A, et al. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy. 1997;52:504-13. (Pubitemid 27308740)
2. Torchia D, Francalanci S, Bellandi S, et al. Multiple physical urticarias. Postgrad Med J. 2008;84:e1-2.
3. Magerl M, Borzova E, Gimenez-Arnau A, et al. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy. 2009;64:1715-21. This guideline describes diagnostic approaches for all inducible urticarias
4. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427-43. In this guideline, treatment options for urticaria are evaluated and recommendations for management are provided.
5. Silpa-archa N, Kulthanan K. Pinkaew S Physical urticaria: prevalence, type and natural course in a tropical country. J Eur Acad Dermatol Venereol: JEADV. 2011;25:1194-9.
6. Taskapan O. Harmanyeri Y Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol: JEADV. 2006;20:58-62.
7. Zuberbier T. Maurer M Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol. 2007;87:196-205. (Pubitemid 47226886)
8. Herman-Kideckel SM, Cadesky K, Sussman D, et al. Association of dermographic urticaria with the use of progesterone in cottonseed oil. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2011;106:439-40.
9. Adcock BB, Hornsby LB. Jenkins K Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract/Am Board Fam Pract. 2001;14:148-51. (Pubitemid 32240343)
10. Ortonne JP. Urticaria and its subtypes: the role of secondgeneration antihistamines. Eur J Intern Med. 2012;23:26-30.
11. Toda S, Takahagi S, Mihara S, et al. Six cases of antihistamineresistant dermographic urticaria treated with oral ciclosporin. Allergol Int: Off J Jpn Soc Allergol. 2011;60:547-50. First report about the effects of ciclosporin in antihistamine-resistant urticaria factitia.
12. Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154:177-80. This is the first case series on successful treatment of physical urticaria with omalizumab.
13. Borzova E, Rutherford A, Konstantinou GN, et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. J Am Acad Dermatol. 2008;59:752-7. Report of UVB-therapy in urticaria factitia and its beneficial effect on itch.
14. Cassano N, Mastrandrea V, Vestita M, et al. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther. 2009;22 Suppl 1:S22-26.
15. Nettis E, Colanardi MC, Soccio AL, et al. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2006;155:1279-82. (Pubitemid 44730008)
16. Grundmann SA, Kiefer S, Luger TA, et al. Delayed pressure urticaria -dapsone heading for first-line therapy? Journal der Deutschen Dermatologischen Gesellschaft. J Ger Soc Dermatol: JDDG. 2011;9:908-12. This study describes benefits of dapson therapy in patients with antihistamine-resistant delayed pressure urticaria.
17. Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy. 2010;65:138-9. First report on succesful treatment of delayed pressure urticaria with omalizumab.
18. Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417-23. (Pubitemid 16021134)
19. Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113: e313-317.
20. Neittaanmaki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636-44. (Pubitemid 15246645)
21. Katsarou-Katsari A, Makris M, Lagogianni E, et al. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol: JEADV. 2008;22:1405-11.
22. Moller A, Henning M, Zuberbier T, et al. [Epidemiology and clinical aspects of cold urticaria]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1996; 47:510-514. (Pubitemid 26244745)
23. Koeppel MC, Bertrand S, Abitan R, et al. [Urticaria caused by cold. 104 cases]. Annales de dermatologie et de venereologie. 1996;123:627-632. (Pubitemid 26359526)
24. Nakamura Y, Kambe N, Saito M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med. 2009;206:1037-46.
25. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Eng J Med. 2009;360:2416-25.
26. Wasserman SI. Ginsberg MH Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. J Allergy Clin Immunol. 1984;74:275-9. (Pubitemid 14038800)
27. Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213-7. (Pubitemid 18054993)
28. Kaplan AP, Garofalo J, Sigler R, et al. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Eng J Med. 1981;305:1074-7. (Pubitemid 12234832)
29. Mathelier-Fusade P, Aissaoui M, Bakhos D, et al. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134:106-7. (Pubitemid 28087126)
30. Siebenhaar F, Staubach P, Metz M, et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol. 2004;114:1224-5. (Pubitemid 39469169)
31. Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162:198-200. This study shows the relevance of threshold testing in cold contact urticaria for assessing disease activity and efficacy of therapeutic measures.
32. Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review. J Am Acad Dermatol. 2003;48:409-16. (Pubitemid 36337077)
33. Krause K, Zuberbier T. Maurer M Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010;10:243-9.
34. Weinstein ME, Wolff AH. Bielory L Efficacy and tolerability of second-and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:518-22.
35. Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672-9.
36. Magerl M, Schmolke J, Siebenhaar F, et al. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy. 2007;62:1465-8. (Pubitemid 350045589)
37. Metz M, Scholz E, Ferran M, et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:86-92.
38. Magerl M, Pisarevskaja D, Staubach P, et al. Critical temperature threshold measurement for cold urticaria: a randomised controlled trial of H1-antihistamine up-dosing. Br J Dermatol. 2012. This clinical trial shows the safety and efficacy of up-dosing of nonsedating antihistamines in cold contact urticaria.
39. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415-8. (Pubitemid 43795744)
40. Gualdi G, Monari P, Rossi M, et al. Successful treatment of systemic cold contact urticaria with Etanercept in a patient with psoriasis. Br J Dermatol. 2011. This is the first case report regarding the efficacy of Etanercept in cold contact urticaria.
41. Bodar EJ, Simon A, de Visser M, et al. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med. 2009;67:302-5. This is the first case report, about the efficacy of an IL-1 receptor antagonist in cold contact urticaria.
42. Black AK, Sibbald RG. Greaves MW Cold urticaria treated by induction of tolerance. Lancet. 1979;2:964.
43. von Mackensen YA. Sticherling M Cold urticaria: tolerance induction with cold baths. Br J Dermatol. 2007;157:835-6. (Pubitemid 47389893)
44. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417-26.
45. Dice JP. Physical urticaria. Immunol Allergy Clin North Am. 2004;24:225-46. vi. (Pubitemid 38553749)
46. Bullerkotte U, Wieczorek D, Kapp A, et al. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010;65:931-2.
47. Beattie PE, Dawe RS, Ibbotson SH, et al. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol. 2003;139:1149-54. (Pubitemid 37128376)
48. Monfrecola G, Masturzo E, Riccardo AM, et al. Solar urticaria: a report on 57 cases. A J Contact Dermatitis: Off J Am Contact Dermatitis Soc. 2000;11:89-94. (Pubitemid 30350370)
49. Botto NC, Warshaw EM Solar urticaria. J Am Acad Dermatol. 2008;59:909-20. quiz 921-902.
50. Monfrecola G, Nappa P. Pini D Solar urticaria with delayed onset: a case report. Photodermatol. 1988;5:103-4.
51. Reinauer S, Leenutaphong V. Holzle E Fixed solar urticaria. J Am Acad Dermatol. 1993;29:161-5. (Pubitemid 23221890)
52. Torinuki W. Two patients with solar urticaria manifesting pruritic erythema. J Dermatol. 1992;19:635-7. (Pubitemid 23020575)
53. Norris PG. Hawk JL Bruising and susceptibility to solar urticaria. Br J Dermatol. 1991;124:393.
54. Esdaile B, Grabczynska S. George S Solar urticaria confined to areas of bruising. Photodermatol Photoimmunol Photomed. 2010;26:211-2.
55. Beissert S, Stander H. Schwarz T UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030-2. (Pubitemid 30368674)
56. Calzavara-Pinton P, Zane C, Rossi M, et al. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2011.
57. Guzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563-5.
58. Waibel KH, Reese DA, Hamilton RG, et al. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2010;125:490-1.
59. Duchini G, Baumler W, Bircher AJ, et al. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed. 2011;27:336-7.
60. Llamas-Velasco M, Argila DD, Eguren C, et al. Solar urticaria unresponsive to intravenous immunoglobulins. Photodermatol Photoimmunol Photomed. 2011;27:53-4.
61. Hughes R, Cusack C, Murphy GM, et al. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol. 2009;34:e660-662.
62. Correia I, Silva J, Filipe P, et al. Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed. 2008; 24:330-1.
63. Haylett AK, Nie Z, Brownrigg M, et al. Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH. Br J Dermatol. 2011;164:407-14. This study demonstrates the efficacy of a single-dose α-MSH analogue implant in the prevention of solar urticaria symptoms.
64. Mathelier-Fusade P, Vermeulen C. Leynadier F [Vibratory angioedema]. Ann Dermatol Venereol. 2001;128:750-2. (Pubitemid 32694876)